Annual Total Assets
$788.91 M
+$116.33 M+17.30%
31 December 2023
Summary:
Travere Therapeutics annual total assets is currently $788.91 million, with the most recent change of +$116.33 million (+17.30%) on 31 December 2023. During the last 3 years, it has risen by +$181.47 million (+29.88%). TVTX annual total assets is now at all-time high.TVTX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$504.41 M
-$46.71 M-8.48%
30 September 2024
Summary:
Travere Therapeutics quarterly total assets is currently $504.41 million, with the most recent change of -$46.71 million (-8.48%) on 30 September 2024. Over the past year, it has dropped by -$328.44 million (-39.44%). TVTX quarterly total assets is now -39.44% below its all-time high of $832.85 million, reached on 30 September 2023.TVTX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TVTX Total Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +17.3% | -39.4% |
3 y3 years | +29.9% | -34.9% |
5 y5 years | +11.3% | -17.8% |
TVTX Total Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +29.9% | -39.4% | at low |
5 y | 5 years | at high | +30.4% | -39.4% | at low |
alltime | all time | at high | >+9999.0% | -39.4% | >+9999.0% |
Travere Therapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $504.41 M(-8.5%) |
June 2024 | - | $551.12 M(-16.9%) |
Mar 2024 | - | $663.55 M(-15.9%) |
Dec 2023 | $788.91 M(+17.3%) | $788.91 M(-5.3%) |
Sept 2023 | - | $832.85 M(+13.1%) |
June 2023 | - | $736.43 M(-8.9%) |
Mar 2023 | - | $808.23 M(+20.2%) |
Dec 2022 | $672.59 M(-13.4%) | $672.59 M(-7.4%) |
Sept 2022 | - | $726.22 M(-6.8%) |
June 2022 | - | $779.49 M(-5.9%) |
Mar 2022 | - | $828.40 M(+6.7%) |
Dec 2021 | $776.63 M(+27.9%) | $776.63 M(+0.2%) |
Sept 2021 | - | $775.08 M(+3.8%) |
June 2021 | - | $746.77 M(-2.3%) |
Mar 2021 | - | $764.04 M(+25.8%) |
Dec 2020 | $607.44 M(+0.4%) | $607.44 M(-12.2%) |
Sept 2020 | - | $692.22 M(+2.0%) |
June 2020 | - | $678.69 M(+18.4%) |
Mar 2020 | - | $573.06 M(-5.2%) |
Dec 2019 | $604.80 M(-14.7%) | $604.80 M(-1.5%) |
Sept 2019 | - | $613.82 M(-5.2%) |
June 2019 | - | $647.57 M(-3.0%) |
Mar 2019 | - | $667.67 M(-5.9%) |
Dec 2018 | $709.16 M(+36.3%) | $709.16 M(-1.0%) |
Sept 2018 | - | $716.19 M(+45.8%) |
June 2018 | - | $491.14 M(-1.9%) |
Mar 2018 | - | $500.79 M(-3.8%) |
Dec 2017 | $520.35 M | $520.35 M(-0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2017 | - | $520.51 M(+2.6%) |
June 2017 | - | $507.13 M(-0.6%) |
Mar 2017 | - | $510.38 M(-2.8%) |
Dec 2016 | $525.28 M(+2.5%) | $525.28 M(-1.3%) |
Sept 2016 | - | $532.42 M(-0.3%) |
June 2016 | - | $533.97 M(+5.3%) |
Mar 2016 | - | $507.10 M(-1.0%) |
Dec 2015 | $512.26 M(+278.1%) | $512.26 M(+0.1%) |
Sept 2015 | - | $511.63 M(+20.3%) |
June 2015 | - | $425.14 M(+2.2%) |
Mar 2015 | - | $415.99 M(+207.1%) |
Dec 2014 | $135.47 M(+560.9%) | $135.47 M(-7.2%) |
Sept 2014 | - | $145.93 M(-6.2%) |
June 2014 | - | $155.54 M(+65.4%) |
Mar 2014 | - | $94.05 M(+358.8%) |
Dec 2013 | $20.50 M(+757.2%) | $20.50 M(-4.1%) |
Sept 2013 | - | $21.36 M(+699.4%) |
June 2013 | - | $2.67 M(-46.0%) |
Mar 2013 | - | $4.95 M(>+9900.0%) |
Dec 2012 | $2.39 M(>+9900.0%) | - |
Nov 2012 | - | $3900.00(0.0%) |
Aug 2012 | - | $3900.00(0.0%) |
May 2012 | - | $3900.00(0.0%) |
Feb 2012 | - | $3900.00(0.0%) |
Feb 2012 | $3900.00(-2.5%) | - |
Nov 2011 | - | $3900.00(0.0%) |
Aug 2011 | - | $3900.00(-2.5%) |
Feb 2011 | $4000.00 | $4000.00 |
FAQ
- What is Travere Therapeutics annual total assets?
- What is the all time high annual total assets for Travere Therapeutics?
- What is Travere Therapeutics annual total assets year-on-year change?
- What is Travere Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Travere Therapeutics?
- What is Travere Therapeutics quarterly total assets year-on-year change?
What is Travere Therapeutics annual total assets?
The current annual total assets of TVTX is $788.91 M
What is the all time high annual total assets for Travere Therapeutics?
Travere Therapeutics all-time high annual total assets is $788.91 M
What is Travere Therapeutics annual total assets year-on-year change?
Over the past year, TVTX annual total assets has changed by +$116.33 M (+17.30%)
What is Travere Therapeutics quarterly total assets?
The current quarterly total assets of TVTX is $504.41 M
What is the all time high quarterly total assets for Travere Therapeutics?
Travere Therapeutics all-time high quarterly total assets is $832.85 M
What is Travere Therapeutics quarterly total assets year-on-year change?
Over the past year, TVTX quarterly total assets has changed by -$328.44 M (-39.44%)